Fractional exhaled nitric oxide (FeNO) in chronic obstructive respiratory diseases is associated with the bronchodilator response. [PDF]
Nguyen TC +5 more
europepmc +1 more source
Understanding Chronic Obstructive Pulmonary Disease Management and Treatment Patterns in General Medicine: Results From the ASTER Study in Italy. [PDF]
Genga G +6 more
europepmc +1 more source
Exploring the role of sex in asthma and COPD pharmacological treatment. [PDF]
Calzetta L +5 more
europepmc +1 more source
Development of a Scoring System to Predict Suboptimal Peak Inspiratory Flow in Patients With Chronic Obstructive Pulmonary Disease. [PDF]
Kim SH +9 more
europepmc +1 more source
Efficacy and Safety of Dupilumab in Children With Moderate-to-Severe Asthma: A Systematic Review of Emerging Phase 3 Evidence. [PDF]
Ghadah A +8 more
europepmc +1 more source
Integrating blood eosinophils and exhaled nitric oxide (FeNO) in asthma diagnostic pathways for adults and children: the PROPULSION SANTÉ observational study with translational sub-studies (DIVE, DIVE2)-protocols. [PDF]
Gronnier M +15 more
europepmc +1 more source
Comparison of ERS/ATS guidelines across versions: differences in the application of bronchodilator responsiveness criteria in pediatric asthma by age subgroups (2005 vs 2021). [PDF]
Zhao J +6 more
europepmc +1 more source
[Bronchodilating agents. Prevention and therapy].
openaire +1 more source
Paradigm Shift in the Treatment of Chronic Obstructive Pulmonary Disease Improves Patient Outcomes. [PDF]
Huang YJ +6 more
europepmc +1 more source
Safety and Efficacy of Dupilumab, Omalizumab, and Mepolizumab in Moderate-to-Severe Asthma: A Systematic Review. [PDF]
O Omar ZT +7 more
europepmc +1 more source

